Skip to main content

Table 7 Summary of drug-related adverse events in the 184 patients with metastatic renal cell carcinoma

From: Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma

Drug-related adverse event None Any grade Grade 1–2 Grade 3–4
Hand-foot syndrome 63 (34.2) 121(65.8) 112 (60.6) 9 (4.9)
Diarrhea 86 (46.7) 98 (53.3) 93 (50.5) 5 (2.7)
Nausea 110 (59.8) 74 (40.2) 74 (40.2) 0 (0.0)
Fatigue 106 (57.6) 78 (42.4) 78 (42.4) 0 (0.0)
Hypertension 125 (69.6) 59 (32.1) 55 (29.9) 4 (2.2)
Thrombocytopenia 144 (78.3) 40 (21.7) 38 (20.7) 2 (1.1)
Leukocytopenia 147 (79.9) 37 (20.1) 35 (19.0) 2 (1.1)
Anemia 156 (84.8) 28 (15.2) 26 (14.1) 2 (1.1)
Elevation of ALT 160 (87.0) 24 (13.0) 23 (11.5) 1 (0.5)
Alopecia 167 (90.8) 17 (9.2) 17 (9.2) 0 (0.0)
Hypothyroidism 168 (91.3) 16 (8.7) 16 (8.7) 0 (0.0)
  1. All data are presented as the number of patients followed by percentage in parentheses
  2. ALT, alanine aminotransferase